Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil

International Journal of Clinical Oncology

Volumn 9, Issue 5, 2004, Pages 388-392

  Hosokawa, Ayumu ^a   Yamada, Yasuhide ^a   Shimada, Yasuhiro ^a   Muro, Kei ^a   Hamaguchi, Tetsuya ^a   Morita, Hideko ^a   Araake, Mari ^a   Orita, Hiromi ^a   Shirao, Kuniaki ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Continuous infusion; Fluorouracil; Prognostic factor; Thymidylate synthase

Indexed keywords

ALKALINE PHOSPHATASE; FLUOROURACIL; THYMIDYLATE SYNTHASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 10944243586     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0425-1     Document Type: Article

References (18)

1. Lokich J, Bothe A, Fine N, et al. (1981) Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 48:2565-2568
2. Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301-308
3. Graf W, Bergström R, Påhlman L, et al. (1994) Appraisal of a model for prediction of prognosis in advanced colorectal cancer. Eur J Cancer 30A:453-457
4. Kemeny N, Brawn DW Jr (1983) Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count. Am J Med 74:786-794
5. Massacesi C, Norman A, Price T, et al. (2000) A clinical nomogram for predicting long-term survival in advanced colorectal cancer. Eur J Cancer 36:2044-2052
6. Köhne CH, Cunningham D, Costanzo FD, et al. (2002) Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 13:308-317
7. Aschele C, Debernardis D, Casazza S, et al. (1999) Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol 17:1760-1770
8. Leichman CG, Lenz HJ, Leichman L, et al. (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 10:3223-3229
9. Okabe H, Tsujimoto H, Fukushima M (1997) Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. Oncol Rep 4:685-690
10. Johnston PG, Fisher ER, Rockette HE, et al. (1994) The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12:2640-2647
11. Assersohn L, Norman A, Cunningham D, et al. (1999) Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer 79: 1800-1805
12. Edler L, Heim ME, Qiuntero C, et al. (1986) Prognostic factors of advanced colorectal cancer patients. Eur J Cancer Clin Oncol 22:1231-1237
13. Graf W, Glimelius B, Påhlman L, et al. (1991) Determinants of prognosis in advanced colorectal cancer. Eur J Cancer 27:1119-1123
14. Massacesi C, Pistilli B, Valeri M, et al. (2002) Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens. Am J Clin Oncol 25:140-148
15. Steinberg J, Erlichman C, Gadalla T, et al. (1992) Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer 28A:1817-1820
16. Chang AE, Steinberg SM, Culnane M, et al. (1989) Determinants of survival in patients with unresectable colorectal liver metastases. J Surg Oncol 40:245-251
17. Webb A, Scott-Mackie P, Cunningham D, et al. (1995) The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9, C-erb B-2, and beta HCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 6:581-587
18. Gonen M, Hummer A, Zervoudakis A, et al. (2003) Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 21:406-412